Literature DB >> 33642975

Effects of Long-Term Endogenous Corticosteroid Exposure on Brain Volume and Glial Cells in the AdKO Mouse.

Jorge Miguel Amaya1, Ernst Suidgeest2, Isabelle Sahut-Barnola3, Typhanie Dumontet3, Nathanaëlle Montanier3, Guilhem Pagès4, Cécile Keller4, Louise van der Weerd2,5, Alberto M Pereira1, Antoine Martinez4, Onno C Meijer1.   

Abstract

Chronic exposure to high circulating levels of glucocorticoids has detrimental effects on health, including metabolic abnormalities, as exemplified in Cushing's syndrome (CS). Magnetic resonance imaging (MRI) studies have found volumetric changes in gray and white matter of the brain in CS patients during the course of active disease, but also in remission. In order to explore this further, we performed MRI-based brain volumetric analyses in the AdKO mouse model for CS, which presents its key traits. AdKO mice had reduced relative volumes in several brain regions, including the corpus callosum and cortical areas. The medial amygdala, bed nucleus of the stria terminalis, and hypothalamus were increased in relative volume. Furthermore, we found a lower immunoreactivity of myelin basic protein (MBP, an oligodendrocyte marker) in several brain regions but a paradoxically increased MBP signal in the male cingulate cortex. We also observed a decrease in the expression of glial fibrillary acidic protein (GFAP, a marker for reactive astrocytes) and ionized calcium-binding adapter molecule 1 (IBA1, a marker for activated microglia) in the cingulate regions of the anterior corpus callosum and the hippocampus. We conclude that long-term hypercorticosteronemia induced brain region-specific changes that might include aberrant myelination and a degree of white matter damage, as both repair (GFAP) and immune (IBA1) responses are decreased. These findings suggest a cause for the changes observed in the brains of human patients and serve as a background for further exploration of their subcellular and molecular mechanisms.
Copyright © 2021 Amaya, Suidgeest, Sahut-Barnola, Dumontet, Montanier, Pagès, Keller, van der Weerd, Pereira, Martinez and Meijer.

Entities:  

Keywords:  glia; glial fibrillary acidic protein; glucocorticoid; ionized calcium binding adaptor molecule 1; myelin basic protein

Year:  2021        PMID: 33642975      PMCID: PMC7902940          DOI: 10.3389/fnins.2021.604103

Source DB:  PubMed          Journal:  Front Neurosci        ISSN: 1662-453X            Impact factor:   4.677


  92 in total

1.  Glucocorticoid receptor activation induces decrease of hippocampal astrocyte number in rats.

Authors:  Yu-Xia Lou; Jing Li; Zhen-Zhen Wang; Cong-Yuan Xia; Nai-Hong Chen
Journal:  Psychopharmacology (Berl)       Date:  2018-08-01       Impact factor: 4.530

2.  Microglia response and in vivo therapeutic potential of methylprednisolone-loaded dendrimer nanoparticles in spinal cord injury.

Authors:  Susana R Cerqueira; Joaquim M Oliveira; Nuno A Silva; Hugo Leite-Almeida; Silvina Ribeiro-Samy; Armando Almeida; João F Mano; Nuno Sousa; António J Salgado; Rui L Reis
Journal:  Small       Date:  2012-11-15       Impact factor: 13.281

3.  Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group.

Authors:  A Angeli; G Osella; A Alì; M Terzolo
Journal:  Horm Res       Date:  1997

4.  Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism.

Authors:  Isabelle Bourdeau; Céline Bard; Bernard Noël; Isabelle Leclerc; Marie-Pierre Cordeau; Manon Bélair; Jacques Lesage; Lucie Lafontaine; André Lacroix
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

5.  Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury.

Authors:  Jin-Moo Lee; Ping Yan; Qingli Xiao; Shawei Chen; Kuang-Yung Lee; Chung Y Hsu; Jan Xu
Journal:  J Neurosci       Date:  2008-03-19       Impact factor: 6.167

6.  Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice.

Authors:  Yanina Revsin; Niels V Rekers; Mieke C Louwe; Flavia E Saravia; Alejandro F De Nicola; E Ron de Kloet; Melly S Oitzl
Journal:  Neuropsychopharmacology       Date:  2008-09-10       Impact factor: 7.853

7.  Small cerebellar cortex volume in patients with active Cushing's syndrome.

Authors:  Alicia Santos; Eugenia Resmini; Iris Crespo; Patricia Pires; Yolanda Vives-Gilabert; Esther Granell; Elena Valassi; Beatriz Gómez-Anson; M Antonia Martínez-Momblán; Maria Mataró; Susan M Webb
Journal:  Eur J Endocrinol       Date:  2014-07-08       Impact factor: 6.664

8.  Reversibility of impaired brain structures after transsphenoidal surgery in Cushing's disease: a longitudinal study based on an artificial intelligence-assisted tool.

Authors:  Bo Hou; Lu Gao; Lin Shi; Yishan Luo; Xiaopeng Guo; Geoffrey S Young; Lei Qin; Huijuan Zhu; Lin Lu; Zihao Wang; Ming Feng; Xinjie Bao; Renzhi Wang; Bing Xing; Feng Feng
Journal:  J Neurosurg       Date:  2020-01-03       Impact factor: 5.115

9.  Environmental noise exposure modifies astrocyte morphology in hippocampus of young male rats.

Authors:  Odelie Huet-Bello; Yaveth Ruvalcaba-Delgadillo; Alfredo Feria-Velasco; Rocío E González-Castañeda; Joaquín Garcia-Estrada; Miguel A Macias-Islas; Fernando Jauregui-Huerta; Sonia Luquin
Journal:  Noise Health       Date:  2017 Sep-Oct       Impact factor: 0.867

10.  Widespread reductions of white matter integrity in patients with long-term remission of Cushing's disease.

Authors:  Steven J A van der Werff; Cornelie D Andela; J Nienke Pannekoek; Onno C Meijer; Mark A van Buchem; Serge A R B Rombouts; Roos C van der Mast; Nienke R Biermasz; Alberto M Pereira; Nic J A van der Wee
Journal:  Neuroimage Clin       Date:  2014-02-10       Impact factor: 4.881

View more
  7 in total

1.  Cell type specificity of glucocorticoid signaling in the adult mouse hippocampus.

Authors:  Eva M G Viho; Jacobus C Buurstede; Jari B Berkhout; Ahmed Mahfouz; Onno C Meijer
Journal:  J Neuroendocrinol       Date:  2021-12-22       Impact factor: 3.870

2.  Mineralocorticoid receptor status in the human brain after dexamethasone treatment: a single case study.

Authors:  Anne-Sophie C A M Koning; Philippe C Habets; Marit Bogaards; Jan Kroon; Hanneke M van Santen; Judith M de Bont; Onno C Meijer
Journal:  Endocr Connect       Date:  2022-03-14       Impact factor: 3.335

3.  Gene expression changes in the brain of a Cushing's syndrome mouse model.

Authors:  Jorge Miguel Amaya; Eva M G Viho; Hetty C M Sips; Reshma A Lalai; Isabelle Sahut-Barnola; Typhanie Dumontet; Nathanaëlle Montanier; Alberto M Pereira; Antoine Martinez; Onno C Meijer
Journal:  J Neuroendocrinol       Date:  2022-04-01       Impact factor: 3.870

4.  Gene Dysregulation in the Adult Rat Paraventricular Nucleus and Amygdala by Prenatal Exposure to Dexamethasone.

Authors:  Tyler R Rivet; Christine Lalonde; T C Tai
Journal:  Life (Basel)       Date:  2022-07-19

5.  Association between use of systemic and inhaled glucocorticoids and changes in brain volume and white matter microstructure: a cross-sectional study using data from the UK Biobank.

Authors:  Merel van der Meulen; Jorge Miguel Amaya; Olaf M Dekkers; Onno C Meijer
Journal:  BMJ Open       Date:  2022-08-30       Impact factor: 3.006

Review 6.  Long-term effects of glucocorticoid excess on the brain.

Authors:  Alies J Dekkers; Jorge Miguel Amaya; Merel van der Meulen; Nienke R Biermasz; Onno C Meijer; Alberto M Pereira
Journal:  J Neuroendocrinol       Date:  2022-08-18       Impact factor: 3.870

Review 7.  The Impact of Obesity on Microglial Function: Immune, Metabolic and Endocrine Perspectives.

Authors:  Vasileia Ismini Alexaki
Journal:  Cells       Date:  2021-06-23       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.